Bioray Biotech CoROCO:7561 83 OCF Margin % is 50.49% as of Dec. 2025, which is 581% above its 10-year median of 7.41. GuruFocus rates ROCO:7561 with a GF Score™ of 83/100 and a GF Value™ of NT$29.45 (Significantly Undervalued). Among 959 Drug Manufacturers companies, Bioray Biotech Co ranks better than 94.06% on this metric.
The historical rank and industry rank for Bioray Biotech Co's OCF Margin % or its related term are showing as below:
ROCO:7561'
s OCF Margin % Range Over the Past 10 Years
Min: -0.4 Med: 7.41 Max: 34.25
Current: 32.16
During the past 9 years, the highest OCF Margin % of Bioray Biotech Co was 34.25%. The lowest was -0.40%. And the median was 7.41%.
ROCO:7561's OCF Margin % is ranked better than 94.06% of 959
companies
in the Drug Manufacturers industry
Industry Median: 9.95
vs ROCO:7561: 32.16
Bioray Biotech Co OCF Margin % Related Terms
Bioray Biotech Co OCF Margin % Historical Data
* Premium members only.
The historical data trend for Bioray Biotech Co's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Bioray Biotech Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bioray Biotech Co OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Bioray Biotech Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Bioray Biotech Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bioray Biotech Co (ROCO:7561) has a OCF Margin % of 50.49% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Bioray Biotech Co and its competitors. This is 581% above median its historical median of 7.41. According to the industry distribution chart, Bioray Biotech Co ranks #57 out of 959 companies in the Drug Manufacturers industry, placing it in the top 5.9%.
Is Bioray Biotech Co's OCF Margin % too high?
Bioray Biotech Co's current OCF Margin % of 50.49% is 581% above median its 10-year median of 7.41. The Drug Manufacturers industry median OCF Margin % is 9.95. Bioray Biotech Co's value of 50.49% is 407.4% above this industry median. Based on the distribution chart, Bioray Biotech Co ranks #57 out of 959 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Bioray Biotech Co has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bioray Biotech Co's OCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Bioray Biotech Co ranks #57 out of 959 companies for OCF Margin %. This places Bioray Biotech Co in the top 6% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 9.95. Bioray Biotech Co's value of 50.49% is 407.4% above this benchmark. While the company's 10-year median is 7.41 vs. the industry median of 9.95, Bioray Biotech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bioray Biotech Co's current OCF Margin % of 50.49% is 407.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Bioray Biotech Co and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bioray Biotech Co's current OCF Margin % is 50.49%, which is 581% above median its own 10-year median of 7.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioray Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Bioray Biotech Co (ROCO:7561) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$29.45, compared to a current price of NT$19.00 — trading 35.5% below its estimated fair value. The current OCF Margin % is 50.49%, which is 581% above median its 10-year median of 7.41 and 407.4% above the Drug Manufacturers industry median of 9.95. Bioray Biotech Co's overall GF Score™ is 83/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Bioray Biotech Co (ROCO:7561), the current OCF Margin % is 50.49% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bioray Biotech Co (ROCO:7561) Overvalued in 2026?
Based on GuruFocus' analysis, Bioray Biotech Co stock appears to be undervalued.
The current stock price of NT$19.00 is trading 35.5% below its estimated GF Value™ of NT$29.45.
GuruFocus considers Bioray Biotech Co to be Significantly Undervalued.
Key valuation signals for ROCO:7561:
OCF Margin %: 50.49% (581% above median its 10-year median of 7.41)
GF Value™: NT$29.45 vs. price of NT$19.00 (35.5% below fair value)
Industry Position: 407.4% above the Drug Manufacturers median (#57 of 959)
No single metric tells the full story. See the ROCO:7561 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bioray Biotech Co Ltd is engaged in the development and manufacturing of biological agents, including functional probiotics, medicinal fungi, and immune cell preparations.
83GF Score
Get the complete analysis for ROCO:7561
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7561 has been successfully added to your 
